BioNTech SE (BNTX)
86.52
+1.88
(+2.22%)
USD |
NASDAQ |
Jun 24, 16:00
86.63
+0.11
(+0.13%)
After-Hours: 20:00
BioNTech Research and Development Expense (Annual): 1.930B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.930B |
| December 31, 2022 | 1.621B |
| December 31, 2021 | 1.123B |
| December 31, 2020 | 736.61M |
| Date | Value |
|---|---|
| December 31, 2019 | 253.57M |
| December 31, 2018 | 168.93M |
| December 31, 2017 | 96.82M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
253.57M
Minimum
2019
1.930B
Maximum
2023
1.133B
Average
1.123B
Median
2021
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc | 10.68B |
| Moderna Inc | 4.845B |
| Cellectis SA | 87.65M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | 31.19M |